Terms ending in 2042
Every in-force patent on Fondation Imagine's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,668,812 | Recombinant Vectors Suitable for the Treatment of Ipex Syndrome Inserm (Institut National de la Santé et de la Recherche Médicale), Université Paris Cité, Assistance Publique-Hôpitaux de Paris (Aphp), Fondation Imagine, Université d'Evry-Val-D'Essonne, Medizinische Hochschule Hannover and Genethon In force · High confidence | Inserm (Institut National de la Santé et de la Recherche Médicale), Université Paris Cité, Assistance Publique-Hôpitaux de Paris (Aphp), Fondation Imagine, Université d'Evry-Val-D'Essonne, Medizinische Hochschule Hannover and Genethon | In force | High confidence |
1 of 1 patent shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.